New hope for COPD patients who Can't tolerate standard breathing machines
NCT ID NCT04840706
Summary
This study aimed to see if a nasal oxygen device called Airvo could help people with COPD who have high carbon dioxide levels but cannot use the standard, more invasive breathing machine (NIV). It compared the Airvo device to standard care over one year, looking at whether it could lower carbon dioxide levels and reduce the number of serious COPD flare-ups. The study was very small and was terminated early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Turku University Hospital
Turku, 20521, Finland
Conditions
Explore the condition pages connected to this study.